These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20630905)

  • 1. Treatment of acute ischemic stroke in patients with cerebral microbleeds: a decision analysis.
    Benbassat J; Baumal R; Herishanu Y
    QJM; 2011 Jan; 104(1):73-82. PubMed ID: 20630905
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A; Dzialowski I; Koch R; Gahn G
    J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The smoking-thrombolysis paradox and acute ischemic stroke.
    Fisher M
    Neurology; 2006 Feb; 66(3):458; author reply 458. PubMed ID: 16476964
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial.
    Torgano G; Zecca B; Monzani V; Maestroni A; Rossi P; Cazzaniga M; Manganaro D; Boiti C; Zilioli E; Borutti G; Falaschi F; Mandelli C
    Cerebrovasc Dis; 2010 Feb; 29(3):275-81. PubMed ID: 20090319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke.
    Prabhakaran S; Rivolta J; Vieira JR; Rincon F; Stillman J; Marshall RS; Chong JY
    Arch Neurol; 2010 May; 67(5):559-63. PubMed ID: 20212195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and outcome after thrombolytic treatment in ischemic stroke patients with high-risk cardioembolic sources and prior subtherapeutic warfarin use.
    Kim YD; Lee JH; Jung YH; Choi HY; Nam CM; Yang JH; Cho HJ; Nam HS; Lee KY; Heo JH
    J Neurol Sci; 2010 Nov; 298(1-2):101-5. PubMed ID: 20797733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are anticoagulants better than antiplatelet agents for treatment of acute ischemic stroke?
    Griffin G
    Am Fam Physician; 2003 Oct; 68(7):1307-8. PubMed ID: 14567484
    [No Abstract]   [Full Text] [Related]  

  • 9. SITS-MOST: old myths laid to rest.
    Hallevi H; Grotta JC
    Lancet Neurol; 2007 Apr; 6(4):292-3. PubMed ID: 17362829
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombolytic therapy as early management of ischemic stroke.
    Killeen I
    Am Fam Physician; 1998 Jan; 57(1):24-6, 28-30. PubMed ID: 9447212
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
    Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
    Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
    Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-thrombolytic hyperglycemia and 3-month outcome in acute ischemic stroke.
    Putaala J; Sairanen T; Meretoja A; Lindsberg PJ; Tiainen M; Liebkind R; Strbian D; Atula S; Artto V; Rantanen K; Silvonen P; Piironen K; Curtze S; Häppölä O; Mustanoja S; Pitkäniemi J; Salonen O; Silvennoinen H; Soinne L; Kuisma M; Tatlisumak T; Kaste M
    Cerebrovasc Dis; 2011; 31(1):83-92. PubMed ID: 21079397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of aspirin use plus thrombolysis after acute ischaemic stroke: a further MAST-I analysis. MAST-I Collaborative Group. Multicentre Acute Stroke Trial--Italy.
    Ciccone A; Motto C; Aritzu E; Piana A; Candelise L
    Lancet; 1998 Sep; 352(9131):880. PubMed ID: 9742986
    [No Abstract]   [Full Text] [Related]  

  • 15. Alteplase for acute ischemic stroke.
    Gonzales NR; Grotta JC
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):301-18. PubMed ID: 16716092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local intra-arterial thrombolysis with urokinase for acute ischemic stroke before and after the approval of intravenous tissue plasminogen activator treatment in Taiwan.
    Yang FC; Lin CC; Hsueh CJ; Lee JT; Hsu CH; Lee KW; Peng GS
    Ann Vasc Surg; 2010 Nov; 24(8):1117-24. PubMed ID: 21035704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drop of PT Quick percent value is associated with both symptomatic and asymptomatic intracranial hemorrhage in patients treated with rt-PA for acute ischemic stroke.
    Alonso A; Dempfle CE; Szabo K; Zohsel K; Hennerici MG
    Thromb Res; 2011 Jan; 127(1):65-6. PubMed ID: 20537372
    [No Abstract]   [Full Text] [Related]  

  • 18. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis.
    Dharmasaroja PA; Dharmasaroja P; Muengtaweepongsa S
    J Neurol Sci; 2011 Jan; 300(1-2):74-7. PubMed ID: 20937509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal intracerebral haemorrhage following intravenous thrombolysis for acute ischaemic stroke: A hidden role for cerebral amyloid angiopathy?
    Ntlholang O; Farrell M; Noone I; Charidimou A; Crowe M
    J Neurol Sci; 2015 May; 352(1-2):122-4. PubMed ID: 25829081
    [No Abstract]   [Full Text] [Related]  

  • 20. Does prior aspirin use reduce stroke mortality?
    Karlikaya G; Varlbas F; Demirkaya M; Orken C; Tireli H
    Neurologist; 2006 Sep; 12(5):263-7. PubMed ID: 16990739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.